Sector revisions GlaxoSmithKline Pharmaceuticals Limited NSE India S.E.

Stocks

Market Closed - NSE India S.E. 04:35:08 11/09/2026 pm IST			5-day change	1st Jan Change
2,828.40 ^INR	-0.44%		-4.38%	+14.34%

03/08	GSK India first-quarter profit rises on steady vaccine demand	RE
03/08	GlaxoSmithKline Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI

Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	4m. EPS revision	4m. Revenue rev.	1y. EPS revision	1y. Revenue rev.	Nbr of analysts
GLAXOSMITHKLINE PHARMACEUTICALS LIMITED	-	-	-	-	-	-
ELI LILLY AND COMPANY						29
JOHNSON & JOHNSON						22
ABBVIE INC.						29
ROCHE HOLDING AG						19
NOVARTIS AG						22
ASTRAZENECA PLC						23
AMGEN INC.						29
NOVO NORDISK A/S						23
GILEAD SCIENCES, INC.						27
PFIZER INC.						26
VERTEX PHARMACEUTICALS INCORPORATED						27
BRISTOL-MYERS SQUIBB COMPANY						24
SANOFI						24
GSK PLC						21
CHUGAI PHARMACEUTICAL CO., LTD.						15
TAKEDA PHARMACEUTICAL COMPANY LIMITED						16
BAYER AG						18
TEVA PHARMACEUTICAL INDUSTRIES LIMITED						11
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD						17
Average						22
Weighted average by Cap.						25